ta 993 has been researched along with thromboxane b2 in 1 studies
Studies (ta 993) | Trials (ta 993) | Recent Studies (post-2010) (ta 993) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
---|---|---|---|---|---|
10 | 0 | 0 | 7,483 | 715 | 485 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeo, T; Karasawa, T; Katoh, M; Odawara, A; Takagi, M; Watanabe, A | 1 |
1 other study(ies) available for ta 993 and thromboxane b2
Article | Year |
---|---|
Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Calcium; Collagen; Diltiazem; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2001 |